The Calciphylaxis Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The calciphylaxis global market has shown significant growth in the past years. It increased from $3.22 billion in 2024 to $3.55 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.0%.
The market size of calciphylaxis is predicted to reach $5.13 billion by 2029, with a compound annual growth rate (CAGR) of 9.7%.
Download Your Free Sample of the 2025 Calciphylaxis Market Report and Uncover Key Trends Now!The key drivers in the calciphylaxis market are:
• Rising global aging population
• Advent of therapeutic innovations
• Expanding access to dialysis in developing regions
• Increasing investment in rare disease drug development
The calciphylaxis market covered in this report is segmented –
1) By Type: Non-Uremic Calciphylaxis, Ulcers And Wounds, Debridement Of Wounds
2) By Treatment: Drug Therapy, Hyperbaric Calciphylaxis Therapy
3) By Diagnosis: Deep Skin Biopsies, Blood Tests, Imaging
4) By End-Use: Hospital And Clinics, Homecare, Ambulatory Centers
Subsegments:
1) By Non-Uremic Calciphylaxis: Vascular Calcification, Soft Tissue Calcification, Cutaneous Manifestations
2) By Ulcers and Wounds: Skin Ulcers, Ischemic Wounds, Necrotic Ulcers, Pressure Ulcers
3) By Debridement Of Wounds: Surgical Debridement, Enzymatic Debridement, Autolytic Debridement, Mechanical Debridement, Biological Debridement
The key trends in the calciphylaxis market are:
• Advancements in dialysis and renal care are emerging trends in the calciphylaxis market.
• The development of treatments for mineral and bone disorders is a rising trend.
• The growth in personalized medicine is influencing future developments.
• Biotechnology and therapeutic developments are trends shaping the market.
Major players in the calciphylaxis market are:
• Baxter International Inc.
• Opko Health Inc.
• Hope Pharmaceuticals Ltd.
North America was the largest region in the calciphylaxis market in 2024